Pereira, Maria J.
Uppsala University
4 papers on CoChatORCID 0000-0001-5498-3899
Most cited papers
- Verified
Emerging role of SGLT-2 inhibitors for the treatment of obesity
Pereira, M. J., & Eriksson, J. W. (2019) · Drugs
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 342
- Verified
Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes
Lundkvist, P., Sjöström, C. D., Amini, S., Pereira, M. J., Johnsson, E., & Eriksson, J. W. (2017) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 108
- Verified
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year
Lundkvist, P., Pereira, M. J., Katsogiannos, P., Sjöström, C. D., Johnsson, E., & Eriksson, J. W. (2017) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 72
- Verified
Altered expression of aromatase and estrogen receptors in adipose tissue from men with obesity or type 2 diabetes
Ahmed, F., Hetty, S., Laterveer, R., Surucu, E. B., Mathioudaki, A., Hornbrinck, E., Patsoukaki, V., Olausson, J., Sundbom, M., Svensson, M. K., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism
Estrogen and related hormone effectsAdipokines, Inflammation, and Metabolic Diseases
Cited by 40
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free